Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

Most people who get Covid today will experience only a mild illness. But some people are still at risk of severe illness and are more likely to be hospitalised with Covid . This includes older people, ...

The small-scale study, conducted by researchers at Corewell Health in Grand Rapids, Michigan, and Michigan State University, ...

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Subungual melanoma which appears under fingernails and toenails, is a rare but serious form of skin cancer that typically isn ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Adults who later developed long COVID had lower cardiorespiratory fitness (CRF) before infection than those who did not.

A new study could explain the impact of COVID-19 on the brain and why some people deal with lingering symptoms even years later.

In a collaboration with Corewell Health and the MSU College of Human Medicine, two brain biomarkers were found in long COVID ...